In this podcast, Daniel M. Musher, MD, answers our questions on his systematic review of the etiology of community-acquired pneumonia and briefly discusses his extensive research on community-acquired...
He answers our questions about the factors contributing to the public's lack of trust in the medical community, the advice he gives to lay people who buy into "fake news," and the role health care...
He answers our questions about the factors contributing to the public's lack of trust in the medical community, the advice he gives to lay people who buy into "fake news," and the role health care...
He answers our questions about the factors contributing to the public's lack of trust in the medical community, the advice he gives to lay people who buy into "fake news," and the role health care...
In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment,...
In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment,...
Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly...
Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly...
In this podcast, William Schaffner, MD, talks about updates from the June 2021 Advisory Committee on Immunization Practices (ACIP), including recommendations for influenza vaccine, pneumococcal vaccines for...
In this podcast, William Schaffner, MD, talks about updates from the June 2021 Advisory Committee on Immunization Practices (ACIP), including recommendations for influenza vaccine, pneumococcal vaccines for...
